BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23002446)

  • 1. Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.
    Bellais S; Six A; Fouet A; Longo M; Dmytruk N; Glaser P; Trieu-Cuot P; Poyart C
    J Infect Dis; 2012 Dec; 206(11):1745-52. PubMed ID: 23002446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.
    Meehan M; Cunney R; Cafferkey M
    Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1155-62. PubMed ID: 24469423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.
    Teatero S; McGeer A; Low DE; Li A; Demczuk W; Martin I; Fittipaldi N
    J Clin Microbiol; 2014 May; 52(5):1441-7. PubMed ID: 24554752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.
    Gherardi G; Imperi M; Baldassarri L; Pataracchia M; Alfarone G; Recchia S; Orefici G; Dicuonzo G; Creti R
    J Clin Microbiol; 2007 Sep; 45(9):2909-16. PubMed ID: 17634303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
    Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
    Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.
    Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Carey VJ; Hickman ME; Kasper DL
    J Infect Dis; 2000 Oct; 182(4):1129-38. PubMed ID: 10979909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17/PI-1 and PI-2b sublineage in neonatal infections.
    Lu B; Wu J; Chen X; Gao C; Yang J; Li Y; Wang J; Zeng J; Fang Y; Wang D; Cui Y; Wang L
    J Med Microbiol; 2018 Nov; 67(11):1551-1559. PubMed ID: 30265233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive neonatal GBS infections from an area-based surveillance study in Italy.
    Imperi M; Gherardi G; Berardi A; Baldassarri L; Pataracchia M; Dicuonzo G; Orefici G; Creti R
    Clin Microbiol Infect; 2011 Dec; 17(12):1834-9. PubMed ID: 21722258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilocus sequence typing of invasive group B Streptococcus in central area of Taiwan.
    Tien N; Ho CM; Lin HJ; Shih MC; Ho MW; Lin HC; Lin HS; Chang CC; Lu JJ
    J Microbiol Immunol Infect; 2011 Dec; 44(6):430-4. PubMed ID: 21697020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of invasive and non-invasive group B Streptococcus circulating in Serbia.
    Gajic I; Plainvert C; Kekic D; Dmytruk N; Mijac V; Tazi A; Glaser P; Ranin L; Poyart C; Opavski N
    Int J Med Microbiol; 2019 Jan; 309(1):19-25. PubMed ID: 30389335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved methods for typing nontypeable isolates of group B streptococci.
    Benson JA; Flores AE; Baker CJ; Hillier SL; Ferrieri P
    Int J Med Microbiol; 2002 Jun; 292(1):37-42. PubMed ID: 12139427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group B streptococcus neonatal invasive infections, France 2007-2012.
    Joubrel C; Tazi A; Six A; Dmytruk N; Touak G; Bidet P; Raymond J; Trieu Cuot P; Fouet A; Kernéis S; Poyart C
    Clin Microbiol Infect; 2015 Oct; 21(10):910-6. PubMed ID: 26055414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.
    Alhhazmi A; Pandey A; Tyrrell GJ
    J Clin Microbiol; 2017 Sep; 55(9):2637-2650. PubMed ID: 28615470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occurrence of the hypervirulent ST-17 clone of Streptococcus agalactiae in pregnant women and newborns].
    Brzychczy-Włoch M; Gosiewski T; Pawlik D; Szumała-Kakol A; Samead A; Heczko PB
    Przegl Epidemiol; 2012; 66(3):395-401. PubMed ID: 23230708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population.
    Rosini R; Campisi E; De Chiara M; Tettelin H; Rinaudo D; Toniolo C; Metruccio M; Guidotti S; Sørensen UB; Kilian M; ; Ramirez M; Janulczyk R; Donati C; Grandi G; Margarit I
    PLoS One; 2015; 10(5):e0125985. PubMed ID: 25946017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study.
    Ji W; Zhou H; Li J; Britto CD; Liu Z; Zhang W; Du J; Madhi SA; Kwatra G; Dangor Z; Jin Z; Zhao H; Zhao Y; Fang Y; Li J
    Vaccine; 2024 Jun; 42(16):3564-3571. PubMed ID: 38692955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
    Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
    J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages.
    Campisi E; Rinaudo CD; Donati C; Barucco M; Torricelli G; Edwards MS; Baker CJ; Margarit I; Rosini R
    Sci Rep; 2016 Jul; 6():29799. PubMed ID: 27411639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.